RYBREVANT Delivers Sustained Benefit in Difficult Colorectal Cancer Cases

Longer-Term OrigAMI-1 Results Highlight Durable Activity of Amivantamab-Based Regimens in Metastatic Colorectal Cancer Johnson & Johnson has announced encouraging longer-term follow-up results from the Phase 1b/2 OrigAMI-1 clinical study evaluating amivantamab-vmjw, an investigational bispecific antibody targeting both epidermal growth factor…

Read MoreRYBREVANT Delivers Sustained Benefit in Difficult Colorectal Cancer Cases
Kirin

Kirin Develops Fermented Coffee Cherry Ingredient to Enhance Flavor, Promote Sustainability, and Reduce Alcohol-Related Impact

Kirin Develops Fermented Coffee Cherry Ingredient to Enhance Beverage Quality and Promote Sustainability Kirin Holdings Co., Ltd. announced that its Institute for Future Beverage has successfully developed a unique fermented ingredient derived from coffee cherries*1 — the red fruits of…

Read MoreKirin Develops Fermented Coffee Cherry Ingredient to Enhance Flavor, Promote Sustainability, and Reduce Alcohol-Related Impact
Onchilles

Onchilles Pharma Publishes Breakthrough ELANE Pathway Study and Secures Funding to Advance N17350 Toward Clinical Trials

Onchilles Pharma Publishes Landmark ELANE Pathway Study and Advances N17350 Toward Clinical Trials With $25 Million Series A1 Financing and New Clinical Advisor Peer-reviewed study in Cell Reports Medicine validates ELANE pathway as a cancer-selective, immune-activating mechanism and supports advancement…

Read MoreOnchilles Pharma Publishes Breakthrough ELANE Pathway Study and Secures Funding to Advance N17350 Toward Clinical Trials
Franklin

Franklin Resources Reports Preliminary Fourth Quarter and Full-Year Fiscal Results

Franklin Resources Reports Preliminary Fourth Quarter and Fiscal Year 2025 Results Franklin Resources, Inc. (the “Company”) [NYSE: BEN] today announced preliminary financial results for its fourth quarter and fiscal year ended September 30, 2025. For the quarter, net income was…

Read MoreFranklin Resources Reports Preliminary Fourth Quarter and Full-Year Fiscal Results
Pinterest

Pinterest Reports Strong Q3 2025 Results with 17% Revenue Growth and Record User Engagement

Pinterest Reports Strong Third Quarter 2025 Results with 17% Revenue Growth and Record 600 Million Monthly Active Users Pinterest, Inc. (NYSE: PINS) today announced financial results for the quarter ended September 30, 2025, highlighting continued momentum driven by product innovation…

Read MorePinterest Reports Strong Q3 2025 Results with 17% Revenue Growth and Record User Engagement